ES2194207T3 - Nuevas n-cianoiminas triciclicas utiles como inhibidores de la farnesil-protein-transferasa. - Google Patents

Nuevas n-cianoiminas triciclicas utiles como inhibidores de la farnesil-protein-transferasa.

Info

Publication number
ES2194207T3
ES2194207T3 ES97934269T ES97934269T ES2194207T3 ES 2194207 T3 ES2194207 T3 ES 2194207T3 ES 97934269 T ES97934269 T ES 97934269T ES 97934269 T ES97934269 T ES 97934269T ES 2194207 T3 ES2194207 T3 ES 2194207T3
Authority
ES
Spain
Prior art keywords
farnesil
inhibitors
protein
cyanoimines
triciclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97934269T
Other languages
English (en)
Inventor
Alan B Cooper
James J-S Wang
Raymond G Lovey
Jagdish A Desai
Anil K Saksena
Viyyoor M Girijavallabhan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ES2194207T3 publication Critical patent/ES2194207T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA PRESENTE INVENCION DESCRIBE NUEVOS COMPUESTOS DE N - CIANOIMINA TRICICLICOS Y COMPOSICIONES FARMACEUTICAS QUE SON INHIBIDORES DE LA ENZIMA TRANSFERASA DE FARNESIL - PROTEINA. TAMBIEN SE DESCRIBE UN PROCEDIMIENTO DE INHIBICION DE LA FUNCION RAS Y POR TANTO INHIBICION DEL CRECIMIENTO ANORMAL DE LAS CELULAS. DICHO PROCEDIMIENTO COMPRENDE LA ADMINISTRACION DE DICHO NUEVO COMPUESTO A UN SISTEMA BIOLOGICO. PARTICULARMENTE, EL CITADO PROCEDIMIENTO INHIBE EL CRECIMIENTO ANORMAL DE LAS CELULAS DE UN MAMIFERO, COMO EL HOMBRE.
ES97934269T 1996-07-31 1997-07-29 Nuevas n-cianoiminas triciclicas utiles como inhibidores de la farnesil-protein-transferasa. Expired - Lifetime ES2194207T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69052296A 1996-07-31 1996-07-31

Publications (1)

Publication Number Publication Date
ES2194207T3 true ES2194207T3 (es) 2003-11-16

Family

ID=24772812

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97934269T Expired - Lifetime ES2194207T3 (es) 1996-07-31 1997-07-29 Nuevas n-cianoiminas triciclicas utiles como inhibidores de la farnesil-protein-transferasa.

Country Status (13)

Country Link
EP (1) EP0915869B1 (es)
JP (1) JP3153555B2 (es)
CN (1) CN1117745C (es)
AT (1) ATE240313T1 (es)
AU (1) AU3737097A (es)
CA (1) CA2261724C (es)
CO (1) CO4900031A1 (es)
DE (1) DE69722002T2 (es)
ES (1) ES2194207T3 (es)
ID (1) ID19401A (es)
PE (1) PE92098A1 (es)
WO (1) WO1998004545A1 (es)
ZA (1) ZA976754B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5160350A1 (es) * 1998-12-18 2002-05-30 Schering Corp Inhibidores de transferasa de proteina farnesilo
AR033680A1 (es) * 2000-08-30 2004-01-07 Schering Corp Compuestos triciclicos utiles como inhibidores de la farnesil proteino transferasa y su uso para la manufactura de medicamentos como agentes antitumorales
CN102731476A (zh) * 2012-05-29 2012-10-17 安徽宏业药业有限公司 含氰胍结构的苯并环庚基吡啶衍生物、制备方法、药物组合物及其医药用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826853A (en) * 1986-10-31 1989-05-02 Schering Corporation 6,11-Dihydro-11-(N-substituted-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines and compositions and methods of use
NZ228888A (en) * 1988-04-28 1991-12-23 Schering Corp Derivatives of piperidine, piperidylidene and piperazine and pharmaceutical compositions
ATE210652T1 (de) * 1993-10-15 2001-12-15 Schering Corp Tricyclische carbamat-derivate zur inhibierung der g-protein funktion und für die behandlung von proliferativen erkrankungen
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them

Also Published As

Publication number Publication date
DE69722002D1 (de) 2003-06-18
CN1226246A (zh) 1999-08-18
WO1998004545A1 (en) 1998-02-05
ID19401A (id) 1998-07-09
CA2261724C (en) 2003-05-13
ATE240313T1 (de) 2003-05-15
ZA976754B (en) 1998-02-02
EP0915869A1 (en) 1999-05-19
CO4900031A1 (es) 2000-03-27
PE92098A1 (es) 1998-12-31
DE69722002T2 (de) 2004-04-01
AU3737097A (en) 1998-02-20
CN1117745C (zh) 2003-08-13
CA2261724A1 (en) 1998-02-05
JP2000500783A (ja) 2000-01-25
EP0915869B1 (en) 2003-05-14
JP3153555B2 (ja) 2001-04-09

Similar Documents

Publication Publication Date Title
ES2194987T3 (es) Compuestos triciclicos utiles para inhibir la farnesil-protein-transferasa.
ATE303378T1 (de) Benzothiepinen mit wirkung als inhibitoren des ileumgallensäuretransports und der taurocholate- aufnahme
AR002705A1 (es) Un nuevo compuesto de indolina, un proceso para su preparacion y composiciones farmaceuticas que lo contienen.
ES2162818T3 (es) Quinazolinas anti-proliferativas.
ECSP045139A (es) DERIVADOS DE ACETILENO QUE TIENEN ACTIVIDAD ANTAGONISTICA DE MGluR5
BR9810293A (pt) "região reguladora preferida de tecido masculinoe processo de utilização da mesma"
BRPI0411319A (pt) compostos terapeuticamente ativos e sua utilização
CO7250441A2 (es) Inhibidores de girasa y uso de los mismos
DE50009646D1 (de) Bicyclische heterocyclen, verfahren zu ihrer herstellung und ihre verwendung als herbizide und pharmazeutische mittel
BR9803704A (pt) Quinazolina-4-ona como antagonistas do ampa.
ES2079940T3 (es) Composiciones desinfectantes.
ES2089687T3 (es) 4-fenil-piridonas y 4-fenil-2-alcoxipiridinas sustituidas como inhibidores de la hmg-coa-reductasa.
BR9813969A (pt) Utilização de uma composição no controle de organismos de plantas patogênicas
BR9813536A (pt) "derivados oxima e produtos quìmicos agrìcolas incluindo os mesmos"
ES2092592T3 (es) Dispersiones acuosas de derivados de sulfonilurea.
MX9704037A (es) 1,1-dioxidos de 1,2,5-tiadiazolidin-3-ona 2-substituida y composiciones y metodo de uso de los mismos.
ES2174921T3 (es) Inhibidores de la proteasa del vih.
PA8586801A1 (es) Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
ES2096973T3 (es) Fosfazenos que contienen radicales organicos de silicio, proceso para su preparacion, y su empleo.
ES2144507T3 (es) Potencializador de la actividad pesticida de bacillus.
ES2178761T3 (es) Utilizacion de 1-hidroxi-2-piridonas para el tratamiento de infe cciones cutaneas.
ES2185694T3 (es) Microorganismos para el control biologico de las enfermedades de las plantas.
ES2194207T3 (es) Nuevas n-cianoiminas triciclicas utiles como inhibidores de la farnesil-protein-transferasa.
DK1353681T3 (da) Bifidobakterier i stand til at modvirke diarré
ATE260097T1 (de) Hopfensäuren zur hemmung von staphylococcus aureus